Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Oncology

• Publication date

  2006-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2005.03.6053PMID 16782916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use and outcomes of adjuvant chemotherapy in older women with breast cancer.

  2006cited by this paper
• Breast cancer treatment guidelines in older women.

  2005cited by this paper
• Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer.

  2005cited by this paper
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  2005cited by this paper
• Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

  2005cited by this paper
• The use of the propensity score for estimating treatment effects: administrative versus clinical data

  2005cited by this paper
• Racial disparities in treatment and survival among women with early-stage breast cancer.

  2005cited by this paper
• Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group

  2005cited by this paper
• Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.

  2004cited by this paper
• Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.

  2004cited by this paper
• United States life tables, 2002.

  2004cited by this paper
• Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

  2003cited by this paper
• Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

  2003cited by this paper
• Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.

  2003cited by this paper
• Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer

  2003cited by this paper
• Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population

  2002cited by this paper
• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

  2002cited by this paper
• Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.

  2002cited by this paper
• Utility of the SEER-Medicare Data to Identify Chemotherapy Use

  2002cited by this paper
• Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

  2002cited by this paper
• Patient Demographic and Socioeconomic Characteristics in the SEER-Medicare Database: Applications and Limitations

  2002cited by this paper
• Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer

  2002cited by this paper
• Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.

  2001cited by this paper
• Diversity in death certification: a case vignette approach.

  2001cited by this paper
• Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.

  2001cited by this paper
• Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996

  2001cited by this paper
• Tumor characteristics and clinical outcome of elderly women with breast cancer.

  2000cited by this paper
• Patterns of breast carcinoma treatment in older women

  2000cited by this paper
• Development of a comorbidity index using physician claims data.

  2000cited by this paper
• Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

  1999cited by this paper
• Treatment of early-stage breast cancer.

  1999cited by this paper
• Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study.

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Accuracy of Death Certificates for Coding Coronary Heart Disease as the Cause of Death

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

  1998cited by this paper
• Estimating Causal Effects from Large Data Sets Using Propensity Scores

  1997cited by this paper
• NCCN Breast Cancer Practice Guidelines. The National Comprehensive Cancer Network.

  1996cited by this paper
• The influence of older age on breast cancer treatment decisions and outcome.

  1996cited by this paper
• NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network.

  1996cited by this paper
• Influence of death certificate errors on cancer mortality trends.

  1993cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

  1993cited by this paper
• Cancer treatment and age: patient perspectives.

  1993cited by this paper
• Treatment plans for black and white women with stage II node‐positive breast cancer: The national cancer institute black/white cancer survival study experience

  1992cited by this paper
• Implications of the NIH Consensus Development Conference on the Treatment of Early-Stage Breast Cancer

  1991cited by this paper
• Optimal Matching for Observational Studies

  1989cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis

  2025influential citation
• Omission of multimodal therapy in older adults with high-risk breast cancer

  2025cites this paper
• Treatment Strategies in Elderly Patients With Operable, Hormone Receptor-negative Breast Cancer

  2025cites this paper
• Short-term mortality in older (≥70 years) patients with early breast cancer treated with neo-/adjuvant chemotherapy: A Swedish nationwide retrospective population-based study.

  2025cites this paper
• Adjuvant taxane-based chemotherapy treatment in older patients with early breast cancer: A pooled analysis of five phase III trials from the Hellenic Oncology Research Group.

  2025cites this paper
• Chemotherapy in elderly patients with early breast cancer: a systematic review

  2025cites this paper
• Long term efficacy of adjuvant chemotherapy in elderly patients with early stage breast cancer assessed through SEER database analysis

  2025cites this paper
• Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer.

  2025cites this paper
• Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data

  2024cites this paper
• Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer

  2024cites this paper
• Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study

  2024cites this paper
• Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database

  2023cites this paper
• Research on the Effects of Chemotherapy on Survival Outcomes for Older Patients with Primary Triple-Negative Breast Cancer after Surgery: A Propensity Score Matching and Competing Risk Analysis of the SEER Database

  2023cites this paper
• Evaluation of outcome of chemotherapy for breast cancer patients older than 70 years: A SEER-based study

  2023cites this paper
• Life-Threatening Hematoma in an Elderly Breast Cancer Patient Undergoing Chemotherapy

  2023cites this paper
• Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects

  2022cites this paper
• Metaplastic Matrix-Producing Carcinoma and Apocrine Lobular Carcinoma In Situ Associated with Microglandular Adenosis: A Unique Case Report

  2022cites this paper
• The impact of chemotherapy and survival prediction by machine learning in early Elderly Triple Negative Breast Cancer (eTNBC): a population based study from the SEER database

  2022cites this paper
• Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer

  2022cites this paper
• Effect of adjuvant chemotherapy on the survival outcomes of elderly breast cancer: A retrospective cohort study based on SEER database

  2022cites this paper
• Is adjuvant chemotherapy necessary in older patients with breast cancer?

  2022cites this paper
• Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database

  2022cites this paper
• Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry.

  2021cites this paper
• Systemic therapy for early breast cancer in older adults: current status and prospects

  2021cites this paper
• Evaluation of whether adjuvant chemotherapy can be safely omitted for older female patients with ER-positive, HER2-negative N1 breast cancer: a study based on the SEER database

  2021influential citation
• Comparison of Survival Outcomes Among Patients With Breast Cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases

  2021cites this paper
• Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure

  2021cites this paper
• Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients

  2021cites this paper
• Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).

  2021cites this paper
• Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients

  2021cites this paper
• Real world data on adjuvant treatment of older HER2-positive breast cancer patients - A single institution experience through 8 years.

  2021cites this paper
• Systemic therapy for older patients with early breast cancer.

  2021cites this paper
• The role of radiation therapy and systemic therapies in elderly with breast cancer

  2020cites this paper
• Early-Stage Breast Cancer in Older Adults

  2020cites this paper
• Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer.

  2020cites this paper
• Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis.

  2020cites this paper
• The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: A population‐based observational study

  2020cites this paper
• Adjuvant chemotherapy and survival in women aged 70 years and older with triple-negative breast cancer: a Swedish population-based propensity score-matched analysis.

  2020cites this paper
• Delayed initiation of adjuvant chemotherapy in older women with breast cancer

  2020cites this paper
• Systemic Therapy of Common Tumours in Older Patients: Challenges and Opportunities. A Young International Society of Geriatric Oncology Review Paper

  2020cites this paper
• Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review.

  2020cites this paper
• 21-gene recurrence score testing utilization among older women from different races: A population-based study.

  2020cites this paper
• The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study.

  2020cites this paper
• Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes

  2020cites this paper
• Older breast cancer undertreatment: unconscious bias to undertreat—potential role for the international geriatric radiotherapy group?

  2020cites this paper
• Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics

  2020cites this paper
• Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer.

  2020cites this paper
• A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns

  2020cites this paper
• Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients

  2019cites this paper
• Adjuvant chemotherapy for older patients with breast cancer:  When is the pain worth the gain?

  2019cites this paper
• Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.

  2019cites this paper
• Spezielle Aspekte bezogen auf Organsysteme nach geriatrisch-klinischer Bedeutung

  2019cites this paper
• Treatment of elderly breast cancer patients in a breast center in India.

  2019cites this paper
• Adjuvant Systemic Therapy

  2019cites this paper
• Addressing frailty in patients with breast cancer: A review of the literature.

  2019cites this paper
• Adjuvant treatment and survival in older women with triple negative breast cancer: A Surveillance, Epidemiology, and End Results analysis

  2019cites this paper
• Practical consensus recommendations regarding the management of hormone receptor positive early breast cancer in elderly women

  2018cites this paper
• Individualizing the Approach to the Older Woman with Triple-Negative Breast Cancer

  2018cites this paper
• Breast cancer‐specific survival by age: Worse outcomes for the oldest patients

  2018cites this paper
• Breast Cancer in the Elderly.

  2018cites this paper
• Breast Cancer Treatment in Elderly Patients

  2018cites this paper
• Breast diseases in women over the age of 65 in Monastir, Tunisia

  2018cites this paper
• Individualizing Local-Regional Therapy of Breast Cancer in the Elderly

  2018cites this paper
• Breast Cancer Care in the Elderly Patient

  2017cites this paper
• Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt

  2017cites this paper
• Impact of Diabetes Complications on Breast Cancer Screening, Diagnosis, and Prognosis among Elderly Women with Pre-existing Diabetes Using the SEER-Medicare Dataset

  2017cites this paper
• Impact of adjuvant chemotherapy on survival of women with T1N0M0, hormone receptor negative breast cancer.

  2017cites this paper
• Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527.

  2017cites this paper
• Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis

  2017cites this paper
• Oncologists’ End of Life Treatment Decisions

  2017cites this paper
• Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology

  2017cites this paper
• Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework.

  2017cites this paper
• 4th symposium on primary breast cancer in older women. Theme: putting personalized care into practice (Held: 3 March 2017)

  2017cites this paper
• Operation with less adjuvant therapy for elderly breast cancer.

  2016cites this paper
• Approach and Management of Breast Cancer in the Elderly.

  2016cites this paper
• Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.

  2016cites this paper
• Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

  2016cites this paper
• Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment.

  2016cites this paper
• Adjuvant chemotherapy in elderly patients with breast cancer: key challenges

  2016cites this paper
• Missed Opportunities for Loco-Regional Treatment of Elderly Women with Breast Cancer

  2016cites this paper
• Adjuvant chemotherapy in early breast cancer.

  2016cites this paper
• Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: A propensity score analysis.

  2016cites this paper
• Impact of Adjuvant Chemotherapy in Elderly Breast Patients in Taiwan, A Hospital-Based Study

  2016influential citation
• Treatment of Breast Cancer in the Elderly

  2015cites this paper
• Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast Cancer in Elderly Women with Diabetes Mellitus

  2015cites this paper
• Management of early breast cancer in older women: from screening to treatment

  2015cites this paper
• Vers une approche multidisciplinaire optimale du traitement du cancer du sein chez les patientes plus âgées

  2015cites this paper
• An Analysis of Treatment Patterns, Receipt of Guideline-Concordant Care, and Survival Outcomes among Elderly Women with Non-Metastatic Breast Cancer Using the SEER-Medicare Linked Dataset

  2015cites this paper
• Adjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?

  2015cites this paper
• Breast cancer at extreme ages--a comparative analysis in Chile.

  2015cites this paper
• Variations in Guideline-Concordant Breast Cancer Adjuvant Therapy in Rural Georgia.

  2015cites this paper
• Towards an optimal multidisciplinary approach to breast cancer treatment for older women.

  2015cites this paper
• Special Issues in Older Women with Breast Cancer.

  2015cites this paper
• Optimal management of breast cancer in the elderly patient: current perspectives

  2015cites this paper
• Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population

  2015cites this paper
• Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population‐Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992–2009

  2015cites this paper
• Excellent clinical outcome of triple-negative breast cancer in younger and older women.

  2015cites this paper
• Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy

  2014cites this paper
• Management of Operable Primary Breast Cancer in Older Women

  2014cites this paper
• Management of breast cancer in elderly patients

  2014cites this paper